BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21764403)

  • 1. Important role of population pharmacokinetic/pharmacodynamic modeling in pediatric therapeutics.
    Vinks AA
    J Pediatr; 2011 Sep; 159(3):361-3. PubMed ID: 21764403
    [No Abstract]   [Full Text] [Related]  

  • 2. Population pharmacokinetics of pentobarbital in neonates, infants, and children after open heart surgery.
    Zuppa AF; Nicolson SC; Barrett JS; Gastonguay MR
    J Pediatr; 2011 Sep; 159(3):414-419.e1-3. PubMed ID: 21665222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in brain barbiturate concentration in brain-dead rabbits.
    Saito T; Takeichi S; Osawa M; Yukawa N
    Nihon Hoigaku Zasshi; 1998 Jun; 52(3):177-83. PubMed ID: 9780661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A suicide involving intraperitoneal injection of pentobarbital.
    Hangartner S; Steiner J; Dussy F; Moeckli R; Gerlach K; Briellmann T
    Int J Legal Med; 2016 Sep; 130(5):1217-22. PubMed ID: 26174446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood-brain barrier--an important factor for distribution of hypnotics and their metabolites in the central nervous system].
    Arnold W
    Beitr Gerichtl Med; 1991; 49():103-10. PubMed ID: 1811485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Drug Monitoring of Pentobarbital: Experience at an Academic Medical Center.
    Humble RM; Ehlers A; Pakalniskis BL; Morris C; Drees D; Kulhavy J; Krasowski MD
    Ther Drug Monit; 2015 Dec; 37(6):783-91. PubMed ID: 26565790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aflatoxin B1 on the sensitivity of the rat central nervous system to pentobarbital-Na racemate.
    Stĕtinová V; Grossmann V; Kvĕtina J; Srámek B
    Pol J Pharmacol; 1995; 47(5):393-9. PubMed ID: 8868130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease.
    Su F; El-Komy MH; Hammer GB; Frymoyer A; Cohane CA; Drover DR
    Biopharm Drug Dispos; 2015 Mar; 36(2):104-14. PubMed ID: 25377074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
    Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
    Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic alterations after severe head injury. Clinical relevance.
    Boucher BA; Hanes SD
    Clin Pharmacokinet; 1998 Sep; 35(3):209-21. PubMed ID: 9784934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine as a postoperative sedative after congenital cardiac surgery--Consideration of the anesthetic management has an important role.
    Richards MJ; Eisses M
    Pediatr Crit Care Med; 2010 Sep; 11(5):645-6; author reply 646. PubMed ID: 20823746
    [No Abstract]   [Full Text] [Related]  

  • 12. Dexmedetomidine and pulmonary artery pressure in the pediatric cardiac surgery patient--A new insight.
    Gazit AZ
    Pediatr Crit Care Med; 2010 Sep; 11(5):634-5. PubMed ID: 20823739
    [No Abstract]   [Full Text] [Related]  

  • 13. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedation and imaging protocol.
    Jaffe RB
    Semin Ultrasound CT MR; 1990 Jun; 11(3):181-3. PubMed ID: 2383421
    [No Abstract]   [Full Text] [Related]  

  • 15. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
    Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
    Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recirculatory pharmacokinetic modeling: what goes around, comes around.
    Krejcie TC; Avram MJ
    Anesth Analg; 2012 Aug; 115(2):223-6. PubMed ID: 22826520
    [No Abstract]   [Full Text] [Related]  

  • 17. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dexmedetomidine on pulmonary artery pressure after congenital cardiac surgery: A pilot study.
    Lazol JP; Lichtenstein SE; Jooste EH; Shiderly D; Kudchadker NA; Tatum GH; Orr RA; Wearden PD; Morell VO; Munoz RA; Chrysostomou C
    Pediatr Crit Care Med; 2010 Sep; 11(5):589-92. PubMed ID: 20124943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel zolpidem formulations.
    Owen RT
    Drugs Today (Barc); 2009 May; 45(5):395-400. PubMed ID: 19584967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SOME ASPECTS OF THE PHARMACODYNAMIC ACTIVITY OF 3,5-DIMETHOXY-4-HYDROXYBENZOIC ACID DERIVATIVES].
    VACHER J; DUCHENNE-MARULAZ P; LAKATOS C; FARENC MJ; BUSCH N
    Med Pharmacol Exp Int J Exp Med; 1965; 12():49-55. PubMed ID: 14281477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.